Cardionomic treats reduced cardiac output – ADHF’s root cause – by neuromodulating the terminal branches of the cardiac plexus to benignly increase contractility. Beyond simply relieving dyspnea as current therapies do, Cardionomic’s acute, non-systemic therapy will improve cardiac output, renal blood flow, urine production and pharmacological tolerance.